Tech & Science

Jul 1, 2006
B.C. Biotech Roundtable: Incubation Period
BCBusiness D.B.

For years, B.C.’s biotech sector has rested on the claim that it has spawned two local giants. But the boast is wearing thin. Does B.C. have what it takes to become the next Bay Area, or will we forever be the farm team for big pharmaceuticals eager to pluck the next great drug discovery and stay stuck in an incubation period? BCBusiness sat down with a round table to discuss.

Jul 1, 2006
Aspreva Pharmaceuticals: Biotech Breakthrough
David Jordan

The Dark Horse of the Year award goes to Aspreva Pharmaceuticals. This young biotech broke through the gate to not only crack the Top 100 public companies list just four years after its inception, but also claim bragging rights as the only biotech in B.C. to record a profit in 2005.

Nov 1, 2005
Industry Tax Credits: Biotech Booster
BCBusiness D.B.

Don’t knock scare tactics. They’ve worked well for B.C.’s so-called fragile biotech industry, whose boosters might say dire predictions are the best way to squeeze industry tax credits out of provincial government coffers.

Sep 1, 2005
Biotech Investing: Looking Fear in the Eye
Gregory Thomas

Sinking cash into biotech darlings such as QLT is not for the squeamish, but the payoff could be sweet. Paul Hastings lives in the tortured aftermath of great expectations. Two years before he left northern California to take the helm...

Copyright © Canada Wide Media Limited. All Rights Reserved
230, 4321 Still Creek Drive Burnaby, B.C. V5C 6S7, 604-299-7311
Use of this site constitutes acceptance of our Terms of Use & Privacy Policy